Year-End Termination

PARRY, ROMANI, DECONCINI & SYMMS for HOFFMANN-LA ROCHE INC

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Oppose importation of unsafe drugs from outside the United States. Oppose efforts to put inappropriate restrictions or limitations on the prescription drug Accutane.

LobbyistCovered position, as disclosed
EDWARD H BAXTER N/A
DENNIS DECONCINI N/A
JOHN HADDOW N/A
JAMES ROCK N/A
ROMANO ROMANI N/A
THADDEUS E STROM N/A
STEVE SYMMS N/A

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

Oppose importation of unsafe drugs from outside the United States. Oppose amendments to weaken the Drug Price Competition and Patent Term Restoration Act. Support uniform enforcement of U.S. patent laws. Monitor consideration of S. 1145 and H.R. 1908, the Patent Reform Act of 2005. Support amendments to the bills.

LobbyistCovered position, as disclosed
EDWARD H BAXTER N/A
DENNIS DECONCINI N/A
JOHN HADDOW N/A
JAMES ROCK N/A
ROMANO ROMANI N/A
THADDEUS E STROM N/A
STEVE SYMMS N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1908 (110th), S. 1145 (110th)

Medicare/Medicaid MMM

Support the promulgation of appropriate regulations under the Medicare Prescription Drug Act.

LobbyistCovered position, as disclosed
EDWARD H BAXTER N/A
DENNIS DECONCINI N/A
JOHN HADDOW N/A
JAMES ROCK N/A
ROMANO ROMANI N/A
THADDEUS E STROM N/A
STEVE SYMMS N/A

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.